Phibro Animal Health (PAHC) Liabilities and Shareholders Equity (2013 - 2026)

Phibro Animal Health's Liabilities and Shareholders Equity history runs 14 years deep, the most recent figure standing at $1.4 billion for Q1 2026.

• On a quarterly basis, Liabilities and Shareholders Equity rose 9.71% year-over-year to $1.4 billion in Q1 2026; TTM through Mar 2026 was $5.6 billion, a 22.98% increase from a year earlier, with the FY2025 full-year figure at $1.4 billion, up 38.56% from the prior year.
• Liabilities and Shareholders Equity rose to $1.4 billion in Q1 2026 per PAHC's latest filing, from $1.4 billion in the prior quarter.
• Across five years, Liabilities and Shareholders Equity topped out at $1.4 billion in Q1 2026 and bottomed at $916.2 million in Q1 2022.
• The 5-year median for Liabilities and Shareholders Equity is $972.7 million (2023), against an average of $1.1 billion.
• Across the five-year window, Liabilities and Shareholders Equity gained 0.18% in 2024 and surged 43.39% in 2025, its largest moves.
• Year by year, Liabilities and Shareholders Equity stood at $961.8 million in 2022, then advanced by 1.13% to $972.7 million in 2023, then soared by 32.16% to $1.3 billion in 2024, then gained by 9.34% to $1.4 billion in 2025, then advanced by 2.81% to $1.4 billion in 2026.
• Per Business Quant, the three latest PAHC Liabilities and Shareholders Equity figures stand at $1.4 billion (Q1 2026), $1.4 billion (Q4 2025), and $1.4 billion (Q3 2025).